Global risk of coronary heart disease: assessment and application

Area of Science:

• Cardiology
• Preventive Medicine
• Public Health

Background:

• Coronary heart disease (CHD) remains a leading cause of mortality in the United States.
• The conventional risk factor approach to primary prevention often overlooks individuals who could benefit from interventions.
• A more comprehensive strategy is needed to identify and manage CHD risk effectively.

Purpose of the Study:

• To highlight the advantages of a global risk approach for coronary heart disease (CHD) primary prevention.
• To emphasize how global risk assessment can guide clinical decision-making and improve patient outcomes.
• To promote the adoption of evidence-based tools for estimating CHD risk.

Main Methods:

• Defining global risk of coronary heart disease (CHD) as an absolute risk calculation over a specified period.
• Utilizing empiric equations that integrate major risk factors like blood pressure and cholesterol levels.
• Reviewing available tools, including web-based calculators, for estimating global CHD risk.

Main Results:

• Global risk assessment enables more accurate identification of patients who require preventive therapies.
• Physician prescription of risk-reducing treatments (antihypertensives, statins, aspirin) increases when global risk is known.
• Patient adherence to preventive therapies improves when individuals are aware of their global CHD risk level.

Conclusions:

• The global risk approach offers a superior strategy for primary prevention of coronary heart disease compared to the conventional method.
• Accurate global risk assessment empowers clinicians to prescribe appropriate therapies and patients to engage actively in their cardiovascular health.
• Utilizing validated tools, such as those based on the Framingham Heart Study, is recommended for estimating global CHD risk in the US.